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and stenting 
angioplasty 
The performance ofcarotid angioplasty and stent- 
ing has been advocated asan alternative treatment to
carotid endarterectomy for patients who have carotid 
artery bifurcation stenosis. Recently, some investiga- 
tors have called for a prospective randomized clinical 
trial to compare the two treatment methods. Several 
contemporary prospective randomized clinical trials 
of patients both with symptomatic and with asymp- 
tomatic carotid stenosis have clearly demonstrated 
that carotid endarterectomy is superior to the best 
medical therapy, provided that surgical complication 
rates are within well-defined limits. The surgery- 
related stroke/death rate should be lower than 6% for 
symptomatic patients and lower than 3% for asymp- 
tomatic patients who have severe carotid stenosis. 
Published results of carotid angioplasty and stentlng 
procedures reveal significantly higher stroke/death 
rates than those that have been achieved with carotid 
endarterectomy. Of particular concern is the unac- 
ceptably high complication rate reported with the use 
of this new experimental technology inpatients who 
have asymptomatic carotid bifurcation stenosis. 
The Society for Vascular Surgery (SVS) and the 
International Society for Cardiovascular Surgery, 
North American Chapter (ISCVS-NA) support he 
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investigation, evaluation, and development of new 
and promising treatment methods for patients who 
have carotid artery disease. The safety of any new 
therapy, however, must be clearly established in con- 
trolled and adequately monitored clinical trials under 
Institutional Review Board (IRB) and Food and Drug 
Administration (FDA) guidelines for such therapy. 
When such clinical trials can demonstrate hat 
carotid angioplasty and stenting procedures have a 
treatment-related risk that is comparable with that of 
carotid endarterectomy, a prospective randomized 
trial should be conducted to determine the relative 
efficacy of the two treatment methods. Until the 
safety and efficacy of carotid angioplasty and stenting 
can be proved, the widespread clinical application of 
this technology is not justified. 
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